RACHEL GALAZKA: Open Payments
NPI 1730531021 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,933 in 69 payments from 20 companies in 2025. Trend: 2023 $482 · 2024 $1,361 · 2025 $1,933
Food & beverage: $1,744Education: $189
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $421 |
| Sumitomo Pharma America, Inc. | 13 | $321 |
| Calyxo, Inc. | 3 | $230 |
| Ferring Pharmaceuticals Inc. | 5 | $155 |
| Astellas Pharma US Inc | 3 | $147 |
| ABBVIE INC. | 6 | $118 |
| Boston Scientific Corporation | 1 | $78 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $59 |
| ACCORD HEALTHCARE, INC. | 3 | $50 |
| Caris MPI, Inc. | 1 | $45 |
Products named: ERLEADA, GEMTESA, CVAC ASPIRATION SYSTEM, ADSTILADRIN, BOTOX, XTANDI, Axonics, PYLARIFY.
Industry payments across WA — which companies pay providers there.
